British American Tobacco (LSE:BATS) paid its latest quarterly Dividend on 6 November, adding another instalment to one of the longest income records on the London market. With the shares offering a Yield above 6%, the debate is about how long a shrinking cigarette market can keep funding it, and how much of the burden smokeless products can take on.

A yield that demands attention

As of 7 October 2026, BAT's annual dividend was 245.04p per share, with a trailing 12-month yield of 6.1% and an indicated yield of 6.1%. Company filings show the annual amount is being paid in four equal instalments of 61.26p, in May, August and November 2026 and February 2027. Paying quarterly, rather than the twice-yearly pattern common among UK companies, gives holders a steadier flow of cash through the year.

The growth rate is deliberately modest. The dividend rose 2.0% year on year, a level that shows the board prizes continuity over expansion. The streaks are the attraction: 46 years of continuous payments and 26 years of consecutive increases, which places BAT among the most dependable dividend payers in the UK.

One figure needs care. A Payout Ratio of 0% is shown in the dividend figures, which cannot be right for a company distributing this much cash and is not meaningful. It is a quirk of the calculation rather than a signal about affordability. Investors assessing cover will need to compare the dividend with BAT's own adjusted Earnings and Cash Flow figures instead, since tobacco companies often report adjusted measures that strip out one-off charges and Amortisation of acquired brands.

The 6 November instalment

The November payment of 61.26p was up from 60.06p for the same instalment a year earlier, consistent with that low single-digit rate of growth. The shares went ex-dividend for it on 1 October. Anyone buying on or after the ex-dividend date does not receive the upcoming payment, which goes instead to the previous holder, and the gap between ex-dividend date and payment date is the period in which the company finalises its Shareholder register and arranges the cash.

Because BAT is also listed in the United States, holders there receive the same dividend through American depositary shares, so currency movements between sterling and the dollar can change the amount received in a holder's own money even when the declared pence figure is fixed.

Guidance and the balance sheet

BAT has been steering investors to the lower end of its medium-term growth ranges for 2026. In its 2 June trading update, it said it expected Revenue growth of 3% to 5%, adjusted operating profit growth of 4% to 6% and adjusted Diluted Earnings per Share growth of 5% to 8%, all finishing towards the bottom of those ranges. That outlook has since been maintained, including in half-year materials.

The composition of that growth matters for the income case. The company raised its new categories revenue growth expectation to mid-teens for the first half and full year, up from low double digits. At the same time, it now expects global cigarette industry volumes to fall by about 2.5%, compared with an earlier estimate of around 2%. A faster decline in the core product, offset by faster growth in vapour and oral nicotine, is the essential tension in the stock.

Cash returns extend beyond the dividend. BAT plans £1.3bn of share Buybacks in 2026 and is targeting adjusted net Debt of 2.0 to 2.5 times adjusted earnings before interest, tax, Depreciation and amortisation by the end of the year. It also expects operating cash conversion above 95%. Solid cash generation is ultimately what supports a payout of this scale, and buybacks reduce the number of shares on which future dividends must be paid.

Why the structure of the Business matters

The cigarette business still produces the bulk of the cash, and its Economics are unusual. Volumes decline year after year, but pricing power has historically offset much of that, allowing profits to hold up. The question for LSE:BATS is whether that pricing can continue as regulation tightens and consumers trade down or switch category.

New categories, meaning vapour, heated tobacco and modern oral nicotine, are the company's answer. They are growing quickly from a smaller base and are still working towards the profitability of traditional cigarettes. As they become a larger share of revenue, the dividend will depend increasingly on how well these products convert sales into profit. Regulatory decisions on flavours, taxation and illicit products in major markets could move that timetable in either direction.

Leverage is the other pillar. A company that keeps net debt within its target range retains the freedom to fund both the dividend and buybacks without straining its Credit standing, while a drift above the range would put pressure on one or the other. The dividend is the more protected of the two, since it is set as a multi-year commitment, whereas buybacks can be flexed.

What to watch

The final instalment of the current dividend is due in February 2027, and full-year results are scheduled for 11 February 2027. Those results should bring the next dividend declaration and show whether the second-half profit weighting has come through as management expected. The February instalment will also complete the current cycle of four equal payments, so the next declaration will show whether the board keeps the same low single-digit rate of growth or adjusts it in line with the lower end of earnings guidance. A steady, predictable increase has been the pattern for more than two decades, and that consistency is what income-focused holders will be measuring against.

Investors will also look for any change in the pace of cigarette Volume decline, and whether new category growth has held at the mid-teens rate. Progress on the net debt target and on operating cash conversion will indicate how much room remains for LSE:BATS to keep both the dividend and the buyback on course.